Chia-Jie Lee1, Lin-Hui Su2, Yhu-Chering Huang1, Cheng-Hsun Chiu3. 1. Department of Pediatrics, Chang Gung Children's Hospital, Chang Gung University, College of Medicine, Taoyuan, Taiwan. 2. Department of Laboratory Medicine, Chang Gung Memorial Hospital, Chang Gung University, College of Medicine, Taoyuan, Taiwan. Electronic address: sulh@adm.cgmh.org.tw. 3. Department of Pediatrics, Chang Gung Children's Hospital, Chang Gung University, College of Medicine, Taoyuan, Taiwan; Molecular Infectious Disease Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan. Electronic address: chchiu@adm.cgmh.org.tw.
Abstract
BACKGROUND/ PURPOSE: Typhoid fever is a major cause of disease burden in developing countries. The use of fluoroquinolones, once considered the drugs of choice, should be re-evaluated due to the emergence of quinolone-resistant Salmonella enterica serovar Typhi. In Taiwan, typhoid fever is rare but constitutes an important public health concern. METHODS: In August 2011, two ciprofloxacin-resistant S. Typhi isolates were identified from one patient who had recently travelled to India. The two isolates together with four other ciprofloxacin-susceptible S. Typhi isolates were subjected for molecular investigation. Polymerase chain reaction (PCR) and sequencing were used to analyze the resistance mechanisms. Pulsed-field gel electrophoresis (PFGE) was performed to delineate the genetic relatedness among the isolates. RESULTS: In 2011, a total of 49 typhoid fever cases were reported to the Center for Disease Control in Taiwan, with a significant increase in indigenous cases in northern Taiwan from August to November. In the two S. Typhi isolates with complete resistance to ciprofloxacin [minimum inhibitory concentration (MIC) >32 μg/mL], multiple point mutations in the quinolone resistance-determining regions (QRDRs) of gyrA and parC genes were identified. A unique PFGE pattern was found in the resistant isolates and was different from the other representative susceptible isolates. CONCLUSIONS: The first ciprofloxacin-resistant S. Typhi infection in Taiwan is reported. The emergence and spread of antimicrobial-resistant S. Typhi infection as a result of international travel may become a threat to public health in Taiwan. Clinicians should be well alert when treating patients who may have acquired resistant infections associated with international travel among endemic regions.
BACKGROUND/ PURPOSE:Typhoid fever is a major cause of disease burden in developing countries. The use of fluoroquinolones, once considered the drugs of choice, should be re-evaluated due to the emergence of quinolone-resistant Salmonella enterica serovar Typhi. In Taiwan, typhoid fever is rare but constitutes an important public health concern. METHODS: In August 2011, two ciprofloxacin-resistant S. Typhi isolates were identified from one patient who had recently travelled to India. The two isolates together with four other ciprofloxacin-susceptible S. Typhi isolates were subjected for molecular investigation. Polymerase chain reaction (PCR) and sequencing were used to analyze the resistance mechanisms. Pulsed-field gel electrophoresis (PFGE) was performed to delineate the genetic relatedness among the isolates. RESULTS: In 2011, a total of 49 typhoid fever cases were reported to the Center for Disease Control in Taiwan, with a significant increase in indigenous cases in northern Taiwan from August to November. In the two S. Typhi isolates with complete resistance to ciprofloxacin [minimum inhibitory concentration (MIC) >32 μg/mL], multiple point mutations in the quinolone resistance-determining regions (QRDRs) of gyrA and parC genes were identified. A unique PFGE pattern was found in the resistant isolates and was different from the other representative susceptible isolates. CONCLUSIONS: The first ciprofloxacin-resistant S. Typhi infection in Taiwan is reported. The emergence and spread of antimicrobial-resistant S. Typhi infection as a result of international travel may become a threat to public health in Taiwan. Clinicians should be well alert when treating patients who may have acquired resistant infections associated with international travel among endemic regions.
Authors: Juan José González-López; Nuria Piedra-Carrasco; Fernando Salvador; Virginia Rodríguez; Adrián Sánchez-Montalvá; Anna M Planes; Israel Molina; M Nieves Larrosa Journal: Emerg Infect Dis Date: 2014-11 Impact factor: 6.883
Authors: Sylvie Baucheron; Isabelle Monchaux; Simon Le Hello; François-Xavier Weill; Axel Cloeckaert Journal: Front Microbiol Date: 2014-01-27 Impact factor: 5.640
Authors: Duy Pham Thanh; Abhilasha Karkey; Sabina Dongol; Nhan Ho Thi; Corinne N Thompson; Maia A Rabaa; Amit Arjyal; Kathryn E Holt; Vanessa Wong; Nga Tran Vu Thieu; Phat Voong Vinh; Tuyen Ha Thanh; Ashish Pradhan; Saroj Kumar Shrestha; Damoder Gajurel; Derek Pickard; Christopher M Parry; Gordon Dougan; Marcel Wolbers; Christiane Dolecek; Guy E Thwaites; Buddha Basnyat; Stephen Baker Journal: Elife Date: 2016-03-11 Impact factor: 8.140